Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 61.55
+7.60 (14.09%)
Mar 10, 2026, 11:59 AM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 35.28 billion as of March 9, 2026. Its market cap has increased by 982.52% in one year.
Market Cap
35.28B
Enterprise Value
35.42B
Revenue
1.53B
Ranking
n/a
PE Ratio
112.75
Stock Price
61.55
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 35.28B, an increase of 242.06%. That is a compound annual growth rate of 41.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 35.33B | 49.80% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 36.71B |
| Shanghai Henlius Biotech | 37.50B |
| Shanghai Junshi Biosciences | 32.13B |
| Duality Biotherapeutics | 28.45B |
| Genscript Biotech | 24.99B |
| InnoCare Pharma | 23.79B |
| PegBio | 23.50B |
| 3SBio | 53.95B |